HIV/AIDS Pathogenesis
HIV-1 subtype C Envs elicit potent yet restricted neutralizing antibody response in early infection
Published in TB and Outbreaks Week, July 18th, 2006
According to a study from the United States, "Information about neutralizing antibody responses in subtype C-infected individuals is limited, even though this viral subtype causes the majority of AIDS cases worldwide.
"Here we compared the course and magnitude of the autologous neutralizing antibody (NAb) response against viral envelope (Env) glycoproteins present during acute and early infection with subtypes B and C human immunodeficiency virus type 1 (HIV-1)."
"NAb responses were evaluated in 6 subtype B-infected and 11 subtype...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Antiparasitic Therapy
Moxidectin and ivermectin efficacy similar for Strongyloides fulleborni infection - Antituberculosis Drug Development
Mycobacterium tuberculosis inhibited by gatifloxacin derivatives - Diarrhea Therapy
Regimen of zinc treatment benefits children with diarrhea in Mali - Gastroenteritis Outbreaks
Acute gastroenteritis outbreak associated with sapovirus infection in Osaka City - Tuberculosis Diagnostics
Mycobacterium tuberculosis infection can remain undetected by tuberculin skin testing - Allergy & Immunology
Escherichia coli O157:H7 outer membrane protein A stimulates dendritic cell activation - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
